CME Webcast Teaches on Medical Errors: Causes and Prevention

OSUWexnerbloglogo2014 CME Webcast Teaches on Medical Errors: Causes and Prevention. If a painter or a plumber makes an error, it is annoying. But if doctor of a nurse makes an error, it can be deadly. Fortunately, by creating systems of medical care and promoting a culture of safety, many and maybe even most medical errors can be avoided. On this CME Webcast, we’re going to take a close look at medical errors: why they occur and what we can all do to prevent them. Joining our moderator in the studio is Associate Professor of Surgery and the Associate Chief Quality Officer for Perioperative Services at the Ohio State University, Dr. David Renton.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE and discuss different types of medical errors; and DISCUSS different options for preventing medical errors.

You’ll also learn about the following:

  • Failure of the individual versus failure of a system
  • Just culture
  • Root cause analysis
  • Event reporting systems
  • The problem with verbal orders
  • The Joint Commission and medical errors
  • Reducing ventilator-associated infections
  • Medical error disclosure
  • Electronic medical records and medical errors

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About the Medical Management of Heart Failure on CME Webcast

OSUWexnerbloglogo2014 Learn About the Medical Management of Heart Failure on CME Webcast. Heart failure is an indiscriminate villain and can attack the rich and the poor, man or woman, old or young. But the good news is that we have better medical treatments for heart failure than ever before. On this CME Webcast, we’re going to update you about them. Joining our moderator in the studio are two heart failure cardiologists from the Ohio State University. Dr. Ajay Vallakati is an Assistant Professor and Dr. Brent Lampert is an Associate Professor, both from the Department of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the mechanism of action and indications for sacubitril-valsartan; UNDERSTAND the mechanism of action and indications for ivabradine; DISCUSS the pharmacological management of heart failure; and RECOGNIZE new heart failure therapies including sacubitril-valsartan and ivabradine as well as understand their role in treating heart failure.

You’ll also learn about the following:

  • New medications to treat heart failure
  • Selecting an ACE inhibitor
  • Selecting a diuretic
  • Diastolic versus systolic heart failure treatment
  • Counseling patients about sodium and fluid intake
  • When to place an automatic implantable cardiac defibrillator
  • Follow-up testing of patients with heart failure

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Lung Diseases They Didn’t Teach You About in Medical School

OSUWexnerbloglogo2014 Lung Diseases They Didn’t Teach You About in Medical School. On this CME webcast, we’re going to talk about 10 lung diseases that you probably didn’t learn about in medical school, either because they weren’t discovered at the time, we didn’t have good tests for at the time, or their importance wasn’t known about at the time.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DIAGNOSE and treat recently discovered genetic lung diseases; and DIAGNOSE and treat uncommon pulmonary infections.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Depression in the Setting of Chronic Medical Conditions

OSUWexnerbloglogo2014 Learn About Depression in the Setting of Chronic Medical Conditions. More choices in depression management means more decisions to make in depression management. And more decisions can create a conundrum for physicians. On this CME webcast, we are going to help you navigate the often confusing challenge of treating depression in patients with medical illness. Joining us today is Assistant Professor of Psychiatry, Dr. Kevin Johns.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTANDING how depression impacts other medical conditions; and UNDERSTANDING how to diagnose and treat depression in patients with chronic medical problems.

You’ll also learn about the following:

  • Depression in medical illness
  • Whether the choice of anti-depressant matters

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Preventive Cardiology

OSUWexnerbloglogo2014 CME Webcast Teaches on Preventive Cardiology. The best way to improve outcomes in cardiovascular disease is to not get it in the first place and today on MedNet21, we are going to show you what you can do to prevent heart disease in your patients. Let me welcome today’s guests. Dr. Wesley Milks is a cardiologist and Assistant Professor of Internal Medicine and Kelly Bartsch is a pharmacist specializing in lipid management.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW
the mechanisms of action of the major medication classes utilized in the 2018 multi-society cholesterol guidelines; and UNDERSTAND the influence of the new cardiovascular outcomes trials for ezetimibe and the PCSK9 inhibitors on the new cholesterol guidelines; DEMONSTRATE understanding of key atherosclerotic risk and risk-enhancing factors as well as of recent pivotal lipid lowering treatment guidelines; and SELECT the appropriate target of lipid lowering therapy (e.g. LDL-C or non-HDL-C) with respect to the patient’s comorbid metabolic conditions.

You’ll also learn about the following:

  • Cholesterol level goals
  • Indications for medical treatment of lipids
  • Follow-up of patients started on cholesterol lowering drugs
  • Monitoring of cholesterol lowering drugs
  • CRP and other inflammatory markers

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.